BioTech/Drugs - Cincinnati, OH, US
Created in 2011 as a spin-out of Cincinnati Children's Hospital Medical Center (CCHMC), Airway Therapeutics has extensive expertise in protein development for applications in the lungs and pediatrics. Airway Therapeutics is in advanced preclinical phase of developing AT-100 (rhSP-D), a product targeting bronchopulmonary dysplasia (BPD) in newborns.
Gmail
WP Engine
Mobile Friendly
Google Cloud Hosting
Google Analytics